{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:32Z","timestamp":1786119152269,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/cji.0b013e31819aa31e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:15:40Z","timestamp":1242897340000},"page":"325-332","source":"Crossref","is-referenced-by-count":11,"title":["Mutual Helper Effect in Copulsing of Dendritic Cells With 2 Antigens"],"prefix":"10.1097","volume":"32","author":[{"given":"Jaleh","family":"Shojaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouneh","family":"Dokouhaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Bozorgmehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Nikoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Ahmad","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Akhondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Ostadkarampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Rezania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hassan","family":"Zarnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210219","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0952-7915(97)80153-7","article-title":"Origin, maturation and antigen presenting function of dendritic cells","volume":"9","author":"Cella","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"R2-1-20210219","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"R3-1-20210219","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R4-1-20210219","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/icb.1997.35","article-title":"The role of dendritic cells in T cell activation","volume":"75","author":"Ni","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"R5-1-20210219","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1062060","article-title":"Sensing pathogens and tuning immune responses","volume":"293","author":"Pulendran","year":"2001","journal-title":"Science"},{"key":"R6-1-20210219","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.immunol.18.1.245","article-title":"Dendritic cells in cancer immunotherapy","volume":"18","author":"Fong","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R7-1-20210219","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/89863","article-title":"Dendritic cells: on the move from bench to bedside","volume":"7","author":"Nestle","year":"2001","journal-title":"Nat Med"},{"key":"R8-1-20210219","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.1503","article-title":"Active immunization against cancer with dendritic cells: the near future","volume":"94","author":"Steinman","year":"2001","journal-title":"Int J Cancer"},{"key":"R9-1-20210219","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"key":"R10-1-20210219","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(99)00059-X","article-title":"The control of T cell responses by dendritic cell subsets","volume":"12","author":"Reid","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"R11-1-20210219","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002371-200207000-00001","article-title":"Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity","volume":"25","author":"Zhou","year":"2002","journal-title":"J Immunother"},{"key":"R12-1-20210219","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1078\/0171-2985-00105","article-title":"Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis","volume":"204","author":"Moll","year":"2001","journal-title":"Immunobiology"},{"key":"R13-1-20210219","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1081\/CNV-200029072","article-title":"Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes","volume":"22","author":"Markiewicz","year":"2004","journal-title":"Cancer Invest"},{"key":"R14-1-20210219","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI0216216","article-title":"Cancer vaccines: progress reveals new complexities","volume":"110","author":"Yu","year":"2002","journal-title":"J Clin Invest"},{"key":"R15-1-20210219","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12094-007-0016-5","article-title":"Dendritic cells: still a promising tool for cancer immunotherapy","volume":"9","author":"Aragoneses-Fenoll","year":"2007","journal-title":"Clin Transl Oncol"},{"key":"R16-1-20210219","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.hoc.2006.02.011","article-title":"Dendritic cell-based vaccination against cancer","volume":"20","author":"Saito","year":"2006","journal-title":"Hematol Oncol Clin North Am"},{"key":"R17-1-20210219","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R18-1-20210219","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat Med"},{"key":"R19-1-20210219","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"R20-1-20210219","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma\u2014a feasibility study","volume":"93","author":"Reichardt","year":"1999","journal-title":"Blood"},{"key":"R21-1-20210219","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(01)61767-1","article-title":"Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells","volume":"161","author":"Holtl","year":"1999","journal-title":"J Urol"},{"key":"R22-1-20210219","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2674::AID-CNCR12>3.0.CO;2-Z","article-title":"Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials","volume":"86","author":"Salgaller","year":"1999","journal-title":"Cancer"},{"key":"R23-1-20210219","first-page":"1884","article-title":"Strategies for antigen loading of dendritic cells to enhance the antitumor immune response","volume":"62","author":"Strome","year":"2002","journal-title":"Cancer Res"},{"key":"R24-1-20210219","first-page":"8105","article-title":"Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization","volume":"61","author":"Kotera","year":"2001","journal-title":"Cancer Res"},{"key":"R25-1-20210219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat Med"},{"key":"R26-1-20210219","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3171\/jns.2002.97.3.0611","article-title":"Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12","volume":"97","author":"Yamanaka","year":"2002","journal-title":"J Neurosurg"},{"key":"R27-1-20210219","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.4049\/jimmunol.161.10.5516","article-title":"Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines","volume":"161","author":"Wang","year":"1998","journal-title":"J Immunol"},{"key":"R28-1-20210219","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/08830180600992456","article-title":"Dendritic cell-based immunotherapy","volume":"25","author":"Osada","year":"2006","journal-title":"Int Rev Immunol"},{"key":"R29-1-20210219","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00418-006-0181-6","article-title":"The efficient isolation of murine splenic dendritic cells and their cytochemical features","volume":"126","author":"Zarnani","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"R30-1-20210219","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jri.2007.02.006","article-title":"Immunosuppressive effect of pregnant mouse serum on allostimulatory activity of dendritic cells","volume":"75","author":"Shojaeian","year":"2007","journal-title":"J Reprod Immunol"},{"key":"R31-1-20210219","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.fertnstert.2007.01.102","article-title":"Microenvironment of the feto-maternal interface protects the semiallogenic fetus through its immunomodulatory activity on dendritic cells","volume":"90","author":"Zarnani","year":"2008","journal-title":"Fertil steril"},{"key":"R32-1-20210219","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.173.3.647","article-title":"Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes","volume":"173","author":"Barth","year":"1991","journal-title":"J Exp Med"},{"key":"R33-1-20210219","first-page":"2618","article-title":"Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein","volume":"61","author":"Shimizu","year":"2001","journal-title":"Cancer Res"},{"key":"R34-1-20210219","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0264-410X(02)00534-0","article-title":"Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines","volume":"21","author":"Millard","year":"2003","journal-title":"Vaccine"},{"key":"R35-1-20210219","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.4049\/jimmunol.164.9.4797","article-title":"Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine","volume":"164","author":"Timmerman","year":"2000","journal-title":"J Immunol"},{"key":"R36-1-20210219","first-page":"6445","article-title":"Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines","volume":"61","author":"Schnurr","year":"2001","journal-title":"Cancer Res"},{"key":"R37-1-20210219","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/1521-4141(200106)31:6<1780::AID-IMMU1780>3.0.CO;2-I","article-title":"Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity","volume":"31","author":"Casares","year":"2001","journal-title":"Eur J Immunol"},{"key":"R38-1-20210219","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-065X.2002.18809.x","article-title":"Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction","volume":"188","author":"Rivoltini","year":"2002","journal-title":"Immunol Rev"},{"key":"R39-1-20210219","doi-asserted-by":"crossref","first-page":"14800","DOI":"10.1073\/pnas.93.25.14800","article-title":"The mutation rate and cancer","volume":"93","author":"Tomlinson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R40-1-20210219","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"key":"R41-1-20210219","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0952-7915(99)80014-4","article-title":"Antigen presentation by MHC class I and its regulation by interferon gamma","volume":"11","author":"Fruh","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"R42-1-20210219","first-page":"1153","article-title":"Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon [review]","volume":"8","author":"Giacomini","year":"1988","journal-title":"Anticancer Res"},{"key":"R43-1-20210219","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0065-2776(00)75006-1","article-title":"Strategies for immunotherapy of cancer","volume":"75","author":"Melief","year":"2000","journal-title":"Adv Immunol"},{"key":"R44-1-20210219","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0952-7915(98)80228-8","article-title":"The role of CD4+ T cell responses in antitumor immunity","volume":"10","author":"Pardoll","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"R45-1-20210219","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.189.5.753","article-title":"CD4 T cells and their role in antitumor immune responses","volume":"189","author":"Toes","year":"1999","journal-title":"J Exp Med"},{"key":"R46-1-20210219","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses","volume":"188","author":"Kalams","year":"1998","journal-title":"J Exp Med"},{"key":"R47-1-20210219","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)80218-6","article-title":"CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNg receptor expression by nonhematopoietic cells","volume":"12","author":"Qin","year":"2000","journal-title":"Immunity"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e31819aa31e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:52:31Z","timestamp":1786038751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200905000-00001"}},"subtitle":["A Novel Approach for Improvement of Dendritic-based Vaccine Efficacy Against Tumors and Infectious Diseases Simultaneously"],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e31819aa31e","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}